Currently, research on cervical premalignancy and cervical SqCa depends on a finite number of models, such as cell lines, K14‐HPV16 transgenic mice, and patient‐derived tumor xenotransplantation (PDX). This evidence concerns the gene KRT14 and cervicitis.